Literature DB >> 11206771

Mitral valve repair and transesophageal echocardiographic findings in a high-risk subgroup of patients with active, acute infective endocarditis.

M Senni1, M Merlo, G Sangiorgi, A Gamba, A Procopio, M Glauber, P Ferrazzi.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Limited data are available regarding the efficacy of mitral valve repair in patients affected by active, acute infective endocarditis. In addition, the predictivity of transesophageal echocardiography (TEE) for guiding the surgical decision-making process in these patients has not yet been reported. The study aim was to evaluate the long-term results of mitral valve repair and role of TEE in active, acute infective endocarditis.
METHODS: The study population consisted of patients affected by infective endocarditis of the mitral valve who underwent surgery. TEE was performed intraoperatively to guide the best surgical approach. All patients were followed up (mean 73+/-8 months) after surgery.
RESULTS: Twenty-eight patients underwent surgery for infective endocarditis; of these, 13 had mitral valve repair for active, acute infective endocarditis and formed the basis of the study. Sensitivity, specificity, positive predictive value, negative predictive value of TEE in detecting the mechanism of mitral regurgitation were 87%, 100%, 100% and 92%, respectively. The predictivity test of TEE in guiding surgical strategy was 94%. All patients were alive at the time of follow up; 10 (77%) were in NYHA class I and three in class II (23%). Mitral regurgitation was severe in one patient (8%), moderate in three (23%), mild in four (31%), and absent in five (38%). No relapses of active infective endocarditis were observed during the follow up period.
CONCLUSION: Mitral valve repair appears to be an effective treatment for active, acute infective endocarditis with mitral regurgitation and should be considered as a therapeutic strategy when surgery is contemplated. TEE has a fundamental role in the surgical decision-making process in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11206771

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  6 in total

1.  Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens.

Authors:  G Nadji; J P Rémadi; F Coviaux; A Ali Mirode; A Brahim; M Enriquez-Sarano; C Tribouilloy
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

2.  Mitral valve repair for active culture positive infective endocarditis.

Authors:  G Doukas; M Oc; C Alexiou; A W Sosnowski; N J Samani; T J Spyt
Journal:  Heart       Date:  2005-06-10       Impact factor: 5.994

3.  Mitral valve repair during acute phase infective endocarditis with extensive destruction of the anterior leaflet rough zone and cerebral infarction.

Authors:  Kazuki Hisatomi; Takafumi Yamada; Tomohiro Odate; Kizuku Yamashita; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-19

4.  Outcome of surgical management for active mitral native valve infective endocarditis: a collective review of 57 patients.

Authors:  Takashi Miura; Masayoshi Hamawaki; Shiro Hazama; Koji Hashizume; Tsuneo Ariyoshi; Mizuki Sumi; Akitsugu Furumoto; Nobuo Saito; Akira Tsuneto; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-13

5.  Role of mitral valve repair in active infective endocarditis: long term results.

Authors:  Carlo Rostagno; Enrico Carone; Pier Luigi Stefàno
Journal:  J Cardiothorac Surg       Date:  2017-05-18       Impact factor: 1.637

6.  Should more patients be offered repair for mitral valve endocarditis? a single-centre 15-year experience.

Authors:  Clarissa Ng Yin Ling; David Bleetman; Soumik Pal; Hing Chi Kristie Leung; Habib Khan; Donald Whitaker; Olaf Wendler; Ranjit Deshpande; Max Baghai
Journal:  J Cardiothorac Surg       Date:  2022-09-30       Impact factor: 1.522

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.